| Jody Meredith Haas, NP | |
|
3524 Heathrow Way, Medford, OR 97504-4004 | |
| (541) 646-3505 | |
| Not Available |
| Full Name | Jody Meredith Haas |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 3524 Heathrow Way, Medford, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063274132 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 10021175 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jody Meredith Haas, NP 3524 Heathrow Way, Medford, OR 97504-4004 Ph: (541) 646-3505 | Jody Meredith Haas, NP 3524 Heathrow Way, Medford, OR 97504-4004 Ph: (541) 646-3505 |
News Archive
Pregnant women are an important but thus far largely overlooked group vulnerable to the effects of extreme heat linked to climate change, according to new research by Sabrina McCormick, Ph.D., an Associate Professor of Environmental and Occupational Health at Milken Institute School of Public Health at the George Washington University.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that it has entered into a strategic agreement with Harlan Biotech Israel Ltd (HBI), a leading Good Laboratory Practice contractor, in order to complete pre-clinical safety experiments for the company's innovative therapy for ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease).
A Ludwig Cancer Research study shows that an experimental drug currently in clinical trials can reverse the effects of troublesome cells that prevent the body's immune system from attacking tumors.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with advanced or recurrent endometrial cancer.
Quality of care varies greatly for the treatment of men with early-stage prostate cancer by region of the country and category of health care facility, suggesting the potential for improved patient outcomes with more standard treatment protocols, according to a new study that was published in the Aug. 1 issue of the Journal of Clinical Oncology (2008: Vol. 26, Issue 22).
› Verified 3 days ago
Carla Ann Cochran, NP-C, FNP, AGACNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 555 Black Oak Dr., Suite 300, Medford, OR 97504 Phone: 903-463-0003 | |
Christine Ann Stanek, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2859 State Street, Suite 101, Medford, OR 97504 Phone: 541-282-6505 Fax: 541-282-6520 | |
Lena Lori Varner, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 520 Medical Center Dr Ste 300, Medford, OR 97504 Phone: 541-930-8907 Fax: 541-245-4820 | |
Mrs. Lauren E Hodgdon, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1698 E Mcandrews Rd Ste 200, Medford, OR 97504 Phone: 541-732-5537 | |
Kaitlin Eileen Stapleton, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2900 State St, Medford, OR 97504 Phone: 541-779-1672 | |
Elizabeth L Pethtel, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3170 State St, Medford, OR 97504 Phone: 541-864-8900 Fax: 541-245-3315 | |
Matthew Filoon, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3011 E Barnett Rd, Medford, OR 97504 Phone: 541-789-4673 Fax: 541-789-2121 |